Problem statement: Answer the multiple-choice question.
Question: Which compound exhibits a -2.952% hERG inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
a) CN1C(c2nnnn2-c2ccccc2)c2ccccc2CC1(C)C
b) c1ccc(CSc2nnc(-c3ccco3)n2Cc2ccccc2)cc1
c) C=CCn1cc(C(=O)OCC)c(=O)c2ccc(F)cc21
d) O=S1(=O)CCOCCCN1Cc1ccc(Cl)cc1
e) c1ccc(-c2nc(CSc3n[nH]c(-c4cccs4)n3)cs2)cc1
Answer: a. CN1C(c2nnnn2-c2ccccc2)c2ccccc2CC1(C)C
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CN1C(c2nnnn2-c2ccccc2)c2ccccc2CC1(C)C
CN1C(c2nnnn2-c2ccccc2)c2ccccc2CC1(C)C
2,3,3-trimethyl-1-(1-phenyltetrazol-5-yl)-1,4-dihydroisoquinoline